Ignite Creation Date:
2024-05-06 @ 3:13 AM
Last Modification Date:
2024-10-26 @ 11:30 AM
Study NCT ID:
NCT02236026
Status:
COMPLETED
Last Update Posted:
2017-08-15
First Post:
2014-08-28
Brief Title:
A Study With an Open-Label Active Control to Evaluate the Potential of Nestorone to Delay Cardiac Repolarization in Healthy Female Volunteers
Sponsor:
Population Council
Organization:
Population Council
Study Overview
Official Title:
A Double-Blind Placebo-Controlled Randomized Crossover Design Study With an Open-Label Active Control to Evaluate the Potential of Nestorone to Delay Cardiac Repolarization in Healthy Female Volunteers A Thorough QTQTc Study
Status:
COMPLETED
Status Verified Date:
2017-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of the study is to evaluate the effect of Nestorone NES administered as an bolus injection on the corrected QT interval using Fridericias formula QTcF
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None